Adults vaccine safety surveillance Influenza vaccine safety surveillance data Surveillance of 2020 influenza vaccine safety commenced from 9 April 2020. The current reported event rates are consistent with what are expected according to the existing data. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here. Last updated 04/09/2020 120,384 Adults responded to an SMS about their health a few days after their influenza vaccinations. 94.5% reported no adverse events 94.5% reported no adverse events 5.5% reported any adverse event, including... 0.3% who reported going to a doctor or emergency department in the days after vaccination.The adverse events they reported were similar to the types of adverse events reported overall 6,639 adults reported one or more adverse events. The most commonly reported were: These symptoms are known to occur after vaccination. They are generally mild and short-lived. Meningococcal B vaccine safety surveillance data From July 2020 a meningococcal B vaccine, Bexsero®, is being funded under the National Immunisation Program for Aboriginal and Torres Strait Islander children at 2, 4, and 12 months of age (with a catch up program for Aboriginal and Torres Strait Islander children aged under 2 years until 30 June 2023), and people of all ages with specified medical risk conditions that increase their risk of invasive meningococcal disease. AusVaxSafety is monitoring the safety of Bexsero vaccine. The current reported event rates are consistent with what are expected according to the existing data. For more information on how AusVaxSafety conducts active vaccine safety surveillance click here. Last updated 11/12/2020 756 Adults responded to an SMS about their health a few days after their vaccinations. 80.8% reported no adverse event 80.8% reported no adverse event 19.2% reported any adverse event, including... 1.1% who reported going to a doctor or emergency department in the days after vaccination.The adverse events they reported were similar to the types of adverse events reported overall 145 adults reported one or more adverse events. The most commonly reported were: These symptoms are known to occur after vaccination. They are generally mild and short-lived.
